| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 16, 2021 | Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests | |
| Aug 4, 2021 | Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast | |
| Jun 18, 2021 | Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test | |
| May 4, 2021 | Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast | |
| Mar 18, 2021 | Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast | |
| Feb 23, 2021 | Co-Diagnostics, Inc. Announces New Chief Financial Officer | |
| Dec 14, 2020 | Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold | |
| Nov 25, 2020 | Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test | |
| Nov 17, 2020 | Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests | |
| Nov 16, 2020 | Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07 | |
| Nov 10, 2020 | Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast | |
| Aug 20, 2020 | Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test | |
| Aug 13, 2020 | Co-Diagnostics, Inc. Announces Q2 2020 Results on Form 10-Q | |
| Feb 29, 2020 | FDA allows new diagnostic technologies to test for coronavirus before receiving emergency approvals | The U.S. Food and Drug Administration said today that it would allow new diagnostics technologies to be used to test for the novel coronavirus, COVID-19, at elite academic hospitals and healthcare facilities around the country.
The agency’s... |
| Jan 30, 2020 | FDA outlines product development process to combat Wuhan coronavirus | The FDA on Monday issued a statement explaining how the agency can facilitate the development of investigational products to diagnose, treat and prevent emerging public health threats such as the novel coronavirus (... |
| Jun 12, 2017 | Term Sheet — Monday, June 12 | SUNNY SUNDAY
Good morning! I hope you were all enjoying a lovely Sunday while Uber’s board held a seven-hour meeting to go over the results of Eric Holder’s independent investigation on Uber’s work environment, and reporters on the beat rac... |
| Jan 25, 2012 | Diagnostics firm Lab21 licenses molecular diagnostics technology | Lab21 sells immunodiagnostic assays and is currently developing nucleic acid tests. The company’s tests are used in blood bank screening, medical diagnostics and drug discovery.
Lab21 CEO Graham Mullis said in a statement that the Cooperati... |
| Diagnostics firm Lab21 licenses molecular diagnostics technology | Molecular diagnostics technology developed by Cooperative Diagnostics has caught the eye of United Kingdom firm Lab21 Limited, which has signed an exclusive worldwide license to develop the technology into new personalized medicine tests.
N... |
